Combination salvage chemotherapy with MIZE (ifosfamide-mesna, idarubicin and etoposide) for relapsing or refractory lymphoma. [electronic resource]
Producer: 19980127Description: 595-602 p. digitalISSN:- 1042-8194
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Etoposide -- administration & dosage
- Female
- Humans
- Idarubicin -- administration & dosage
- Ifosfamide -- administration & dosage
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Mesna -- administration & dosage
- Middle Aged
- Recurrence
- Salvage Therapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.